P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.36 MYR -1.37%
Market Cap: 518.8m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Pharmaniaga Bhd

Revenue
3.5B MYR
Cost of Revenue
-3.2B MYR
Gross Profit
323.6m MYR
Operating Expenses
-308.5m MYR
Operating Income
15.1m MYR
Other Expenses
-71.4m MYR
Net Income
-56.3m MYR

Margins Comparison
Pharmaniaga Bhd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
MY
Pharmaniaga Bhd
KLSE:PHARMA
526m MYR
9%
0%
-2%
US
Mckesson Corp
NYSE:MCK
78.4B USD
4%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
49.4B USD
3%
1%
1%
US
Cencora Inc
NYSE:COR
49B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
30B USD
3%
1%
1%
CN
Huadong Medicine Co Ltd
SZSE:000963
63.6B CNY
32%
9%
8%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
US
Henry Schein Inc
NASDAQ:HSIC
8.5B USD
32%
5%
3%
CN
Sinopharm Group Co Ltd
HKEX:1099
66B HKD
8%
4%
1%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.2B CNY
11%
3%
2%
IT
Amplifon SpA
MIL:AMP
5.6B EUR
25%
13%
7%
Country MY
Market Cap 526m MYR
Gross Margin
9%
Operating Margin
0%
Net Margin
-2%
Country US
Market Cap 78.4B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 49.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 49B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 30B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country CN
Market Cap 63.6B CNY
Gross Margin
32%
Operating Margin
9%
Net Margin
8%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country US
Market Cap 8.5B USD
Gross Margin
32%
Operating Margin
5%
Net Margin
3%
Country CN
Market Cap 66B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
1%
Country CN
Market Cap 60.2B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
2%
Country IT
Market Cap 5.6B EUR
Gross Margin
25%
Operating Margin
13%
Net Margin
7%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Pharmaniaga Bhd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
MY
Pharmaniaga Bhd
KLSE:PHARMA
526m MYR
27%
-3%
32%
2%
US
Mckesson Corp
NYSE:MCK
78.4B USD
-105%
4%
27%
18%
US
Amerisourcebergen Corp
LSE:0HF3
49.4B USD
231%
2%
24%
18%
US
Cencora Inc
NYSE:COR
49B USD
231%
2%
24%
18%
US
Cardinal Health Inc
NYSE:CAH
30B USD
-37%
3%
26%
17%
CN
Huadong Medicine Co Ltd
SZSE:000963
63.6B CNY
15%
9%
17%
13%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
US
Henry Schein Inc
NASDAQ:HSIC
8.5B USD
9%
3%
8%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
66B HKD
12%
2%
15%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.2B CNY
6%
2%
10%
5%
IT
Amplifon SpA
MIL:AMP
5.6B EUR
15%
4%
12%
7%
Country MY
Market Cap 526m MYR
ROE
27%
ROA
-3%
ROCE
32%
ROIC
2%
Country US
Market Cap 78.4B USD
ROE
-105%
ROA
4%
ROCE
27%
ROIC
18%
Country US
Market Cap 49.4B USD
ROE
231%
ROA
2%
ROCE
24%
ROIC
18%
Country US
Market Cap 49B USD
ROE
231%
ROA
2%
ROCE
24%
ROIC
18%
Country US
Market Cap 30B USD
ROE
-37%
ROA
3%
ROCE
26%
ROIC
17%
Country CN
Market Cap 63.6B CNY
ROE
15%
ROA
9%
ROCE
17%
ROIC
13%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country US
Market Cap 8.5B USD
ROE
9%
ROA
3%
ROCE
8%
ROIC
5%
Country CN
Market Cap 66B HKD
ROE
12%
ROA
2%
ROCE
15%
ROIC
7%
Country CN
Market Cap 60.2B CNY
ROE
6%
ROA
2%
ROCE
10%
ROIC
5%
Country IT
Market Cap 5.6B EUR
ROE
15%
ROA
4%
ROCE
12%
ROIC
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top